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ORIGINAL ARTICLE
Background/Aims: The development of effective, accurate, and rapid diagnostic methods for Mycobacterium
infection and mycobacterial species identification is required. Polymerase chain reaction-restriction fragment
length polymorphism (PCR-RFLP) is an easy, rapid and inexpensive technique for identifying Mycobacterium spp.
Methods: We performed PCR-RFLP to detect and identify Mycobacterium spp. from 10 sterile body fluids,
including ascites, cerebrospinal fluid, pleural fluid, synovial fluid, and peritoneal dialysis fluid. Clinical samples
were collected from patients with diagnoses of definite, probable or suspected mycobacterial infection. The
conserved RNA polymerase genes of Mycobacterium spp. were amplified by PCR. 
Results: The amplified 360-bp region of rpoB was digested with the restriction enzyme MspI or HaeIII.  The PCR-
RFLP results for the clinical samples were identical to those for M. tuberculosis, M. fortuitum, M. intracellulare, and
M. avium.  In addition, the results of the PCR-RFLP were identical to those obtained by DNA sequencing.
Conclusions: PCR-RFLP analysis of sterile body fluids may be a useful method for the diagnosis of mycobacterial
infections and for the differentiation of mycobacterial species. (Korean J Intern Med 2009;24:135-138)
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INTRODUCTION
Identification of Mycobacterium spp. in clinical speci-
mens is based primarily on culturing and biochemical
tests. These conventional tests take several weeks and
sometimes fail to provide precise identification [1].
Mycobacterial identification at the species level is a critical
step in patient management, as the results obtained
influence decisions on both the optimal therapy and the
need for patient isolation. Therefore, the development of
effective diagnostic methods that allow accurate and rapid
diagnosis of mycobacterial infections and differentiation
among species are urgently required.  Although molecular
diagnostic methods, high-performance liquid chromato-
graphy, and DNA sequence analysis have been investigated,
these methods require substantial effort and are difficult
to implement in the clinical setting [2].  Molecular biological
tests using DNA amplification and probe hybridization
have also been developed.  Using these methods, the dia-
gnosis and differentiation of bacterial species can be
rapidly accomplished.  However, the high costs associated
with these methods make them less attractive in practice
[2-7].
In contrast to these techniques, polymerase chainreaction-restriction fragment length polymorphism (PCR-
RFLP) offers an easy, rapid, and inexpensive way to
identify Mycobacterium spp [7,8]. Therefore, we
attempted to diagnose mycobacterial infections at the
early clinical stages and to differentiate between
Mycobacterium species using PCR-RFLP.  
METHODS
In the present study, we performed PCR-RFLP to detect
and identify Mycobacterium spp. in sterile body fluids,
including ascites, cerebrospinal fluid, pleural fluid,
synovial fluid, and continuous ambulatory peritoneal
dialysis (CAPD) fluid. Clinical samples were collected
from patients who were diagnosed with mycobacterial
infections. A definite tuberculosis (TB) case was defined as
a positive result for M. tuberculosis on culture testing. A
probable TB case was defined as a positive result in an
acid-fast bacilli (AFB) smear, chronic granulomatous
inflammation seen on histopathology, and/or other
positive findings consistent with TB (i.e., a high level of
adenosine deaminase or a positive TB PCR result for
appropriate samples). A suspected TB case was defined as
having typical TB findings by radiology or clinical features
of TB, and showing improvement after treatment. A non-
tuberculous mycobacterial infection (NTMI) was defined
as repeatedly positive results for non-tuberculous
mycobacteria and clinical features associated with
mycobacterial infection. 
Between May, 2001 and July, 2003, sterile specimens
from synovial fluid (n=2), CAPD fluid (n=1), ascites (n=1),
pleural fluid (n=4), and cerebrospinal fluid (n=2) were
obtained. The clinical diagnoses of those patients were:
definite TB (n=1); probable TB (n=3); suspected TB (n=1);
and NTMI (n=5). 
An aliquot (5-20 mL) of each specimen was centrifuged
at 14,000 rpm for 5 min and the supernatant was used for
bacterial DNA extraction. Bacterial genomic DNA was
extracted from clinical specimens using the DNeasy
Tissue Kit (Qiagen, Hilden, Germany). The 360-bp rpoB
gene was amplified by PCR using the following primers:
forward, 5’-TCAAGGAGAAGCGCTACGA-3’; and reverse,
5’-GGATGTTGATCAGGGTCTGC-3’. The PCR consisted
of 35 cycles of preheating at 94˚C for 5 minutes,
denaturation at 94˚C for 1 minute, annealing at 60˚C for
1 minute, and extension at 72˚C for 1 minute, followed by
a final extension step of 72˚C for 7 minutes. The 360-bp
amplified product of rpoB was detected by 2.5% agarose
gel electrophoresis; the gel samples included a 100-bp
DNA ladder, a negative control (distilled water), and a
positive control (360-bp amplified product of rpoB of M.
tuberculosis). The amplified products were digested
separately with  MspI (Boehringer Mannheim Biochemicals,
Mannheim, Germany) and HaeIII (Boehringer Mannheim
Biochemicals) at 37˚C for 2 hours. The digested products
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Table 1. Results of the culture, biopsy, PCR-RFLP, and sequencing analyses of sterile body fluids from patients
Clinical diagnosis Specimens Culture Biopsy PCR-RFLP Sequencing
Definite TB Synovial fluid M. tuberculosis Not done M. tuberculosis M. tuberculosis
NTMI Pleural fluid Atypical  Not done M. avium M. avium
mycobacteria
Probable TB Pleural fluid No growth Granulomatous M. tuberculosis M. tuberculosis
inflammation 
Suspected TB Cerebrospinal fluid No growth Not done M. tuberculosis M. tuberculosis
NTMI Peritoneal  M. fortuitum Not done M. fortuitum M. fortuitum
dialysis fluid
NTMI Cerebrospinal fluid M. avium Not done M. avium M. avium
NTMI Pleural fluid Atypical  Granulomatous  M. intracellulare M. intracellulare
mycobacteria inflammation
Probable TB Ascites No growth Granulomatous  M. tuberculosis M. tuberculosis
inflammation
Suspected TB Pleural fluid No growth Not done M. tuberculosis M. tuberculosis
NTMI Synovial fluid Atypical  Not done M. fortuitum M. fortuitum
mycobacteria
TB, tuberculosis; NTMI, non-tuberculous mycobacterial infection.were separated by 4% agarose gel electrophoresis at 50 V
for 2 hours; the gel samples included a 50-bp DNA ladder,
a negative control (distilled water), and the digested
products of M. avium, M. chelonae, M. fortuitum, M.
gordonae, M. intracellulare, M. kansasii, and M.
tuberculosis (Fig. 1). Reference strains that had been
identified by conventional biochemical testing and rpoB
sequencing were provided by the Department of
Microbiology, Yonsei University College of Medicine [9].
For each specimen, the results of the culture tests,
histologic tests, and clinical diagnoses were compared
with the results of the PCR-RFLP analysis.
The DNA sequence of the PCR-amplified rpoB gene was
analyzed using an rpoB primer and a DNA sequence
analyzer.  Species identification by DNA sequence analysis
was compared with that achieved by PCR-RFLP. 
RESULTS
PCR-RFLP results using 10 clinical samples such as
ascites, cerebrospinal fluid, pleural fluid, synovial fluid,
and CAPD fluid from subjects who were suspected of
having mycobacterial infections were identical to the
PCR-RFLP results of M. tuberculosis, M. fortuitum, M.
intracellulare or M. avium (Table 1). PCR-RFLP results
using the three culture-proven samples coincided with the
results of culture test including M. tuberculosis, M.
fortuitum and M. avium. In the other seven samples that
were not identified by culture, the PCR-RFLP results
provided the precise identification of each Mycobacterium
spp. All of 2 probable and 2 suspected TB cases showed
PCR-RFLP results consistent with M. tuberculosis. PCR-
RFLP results of 3 NTMI cases known partially as atypical
mycobacterium by culture test were consistent with M.
avium, M. intracellulare or M. fortuitum respectively. In
all cases the results of PCR-RFLP were also identical with
those from sequencing.  
DISCUSSION
Currently, laboratory diagnosis of Mycobacterium spp.
infection is made primarily using smear tests and
culturing. The advantage of the smear test is that the
results can be obtained rapidly. However, since mycobac-
terial concentrations of 5×10
3 to 1×10
4/mL are required for
the isolation procedure, the sensitivity of this test is low
and the results may vary depending on the examiner [8-
11]. It has been reported that 30-50% of culture-positive
sputum samples show positive results [8-11]. Although the
sensitivity of the Mycobacterium spp. culture test is
relatively high, it takes 4-8 weeks to obtain the results,
which means that treatment may be delayed and the
bacteria may be transmitted to other people.  Other
shortcomings of these tests are that: 1) during the
pretreatment process, Mycobacterium spp. may be killed;
and 2) the pathogen isolation rate is relatively low in
treated patients. In recent years, molecular methods for
identifying bacteria (e.g., PCR) have been introduced.
These methods overcome the shortcomings of the smear
and culture tests, while maintaining high levels of
sensitivity and specificity [8-11].
In the present study, we examined whether PCR-RFLP
using the rpoB gene could detect and differentiate
between mycobacterial strains present in sterile body
fluids. PCR-RFLP was performed on 10 clinical specimens,
which included synovial fluid, CAPD fluid, ascites, pleural
fluid, and cerebrospinal fluid.  All of the patients were
diagnosed as having or suspected of having Mycobacterium
infection, as confirmed by PCR of the rpoB gene. With
regard to the differentiation of mycobacterial strains, for
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Figure 1. PCR-RFLP analyses of mycobacterial species. (A) PCR-RFLP patterns with MspI. (B) PCR-RFLP patterns with HaeIII. Lane 1, DNA
size marker (50-bp ladder); lane 2, M. avium; lane 3, M. chelonae; lane 4, M. fortuitum; lane 5, M. gordonae; lane 6, M. intracellulare; lane 7,
M. kansasii; lane 8, M. tuberculosis.
A Bsome patients who were diagnosed by culture testing, the
results of the culture and PCR-RFLP were in agreement.
Therefore, the detection and differentiation of strains by
PCR-RFLP is believed to be clinically useful. However, as
the PCR-RFLP method may produce a high number of
false-positives, the overall clinical profile should be con-
sidered when assessing the results for patients.
There have been some reports on the use of PCR-RFLP
for the diagnosis of mycobacterial infections. Kim et al. [5]
reported that by analyzing the rpoB gene, 49 mycobacterial
strains could be differentiated.  In addition, PCR-RFLP
analysis of bronchoalveolar lavage specimens enabled
early diagnosis of mycobacterial infection, and the
mycobacterial strains could be differentiated from
each other.  Similarly, Kontos et al. [12] reported that
Mycobacterium spp. infection could be diagnosed
effectively by culturing clinical specimens in the Bactec
MGIT 960 system, followed by PCR-RFLP analysis.
However, to our knowledge, there have been no studies
using sterile body fluids to evaluate the usefulness of PCR-
RFLP for the diagnosis of patients with mycobacterial
infections and mycobacterial species identification. 
The present study has some limitations. The number
of subjects used was low. Therefore, we could not test the
sensitivity, specificity, and predictive values of the assay.
Moreover, culture-positive results were obtained for only
six patients, and the infecting mycobacterial species was
identified in only three patients. We cannot exclude the
possibility of contamination by environmental mycobacteria.
Furthermore, the false-positive rate of PCR-RFLP may be
high. Finally, the positive control used for PCR-RFLP did
not contain all the mycobacterial species that could be
present in clinical specimens. In spite of these limitations,
to our knowledge, this is the first investigation to focus on
the usefulness of PCR-RFLP using various sterile body
fluids. 
In conclusion, PCR-RFLP analysis using sterile body
fluids may be a useful method for diagnosing mycobacterial
infections and for differentiating among mycobacterial
strains. In the present study, the number of specimens
and strains was low, which meant that the usefulness of
PCR-RFLP analysis could not be compared in a statistically
meaningful way with that of culture testing. Nonetheless,
further studies on the usefulness of PCR-RFLP using
more specimens and species are warranted. 
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